Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001493152-26-022708
Filing Date
2026-05-13
Accepted
2026-05-13 16:05:17
Documents
11
Period of Report
2026-02-20
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K/A form8-ka.htm   iXBRL 8-K/A 34342
  Complete submission text file 0001493152-26-022708.txt   202782

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE imdx-20260220.xsd EX-101.SCH 3080
3 XBRL LABEL FILE imdx-20260220_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE imdx-20260220_pre.xml EX-101.PRE 22402
14 EXTRACTED XBRL INSTANCE DOCUMENT form8-ka_htm.xml XML 3895
Mailing Address 2 INTERNATIONAL PLAZA DR., SUITE 510 NASHVILLE TN 37217
Business Address 2 INTERNATIONAL PLAZA DR., SUITE 510 NASHVILLE TN 37217 949-409-7600
Insight Molecular Diagnostics Inc. (Filer) CIK: 0001642380 (see all company filings)

EIN.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-37648 | Film No.: 26973189
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)